Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United Kingdom. It focuses on depression.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In New YorkThis study is recruiting in China. It focuses on Bipolarity.
In Shanghai
This study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.
Multiple locations, including PhoenixThis study is recruiting in Taiwan. It focuses on anxiety.
In Taipei
This study is recruiting. It focuses on depression and currently lists participation information in Israel.
In HaifaThis study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in Canada.
Multiple locations, including CalgaryThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Italy.
In BresciaThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United Kingdom
This study is recruiting. It focuses on ADHD and currently lists participation information in China.
In JinanThis study is recruiting. It focuses on depression and currently lists participation information in Australia.
In AustraliaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.